Overview

Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment in Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction

Status:
Unknown status

Trial end date:
2015-08-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate whether Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment as 1st line treatment in he advanced gastric cancer is effective and safe.

Phase:

Phase 3

Details

Lead Sponsor:

Peking University

Collaborator:

Roche Pharma AG

Treatments:

Albumin-Bound Paclitaxel
Capecitabine
Cisplatin
Paclitaxel